TY  - RPRT
TI  - PROTAC-mediated dual degradation of BCL-xL and BCL-2 is a highly effective therapeutic strategy in small-cell lung cancer
AU  - Khan, S.
AU  - Cao, L.
AU  - Wiegand, J.
AU  - Zhang, P.
AU  - Zajac-Kaye, M.
AU  - Kaye, F. J.
AU  - Zheng, G.
AU  - Zhou, D.
PY  - 2024
DO  - 10.1101/2024.02.27.582353
UR  - https://www.biorxiv.org/content/10.1101/2024.02.27.582353v1
ID  - 10.1101/2024.02.27.582353
ER  -